Business Wire

NC-ATTINDAS-HYGIENE

12.1.2022 12:06:09 CET | Business Wire | Press release

Share
Attindas Hygiene Partners Announces Lower Carbon Footprint Protective Underwear Products Launching Across Europe

Attindas Hygiene Partners is proud to announce the launch of its reduced carbon emissions adult incontinence protective underwear throughout Europe. By utilizing the new product design, which uses ultrasonic bonding in place of traditional glue adhesive, Attindas is now able to measurably reduce greenhouse gas emissions, including carbon dioxide, to provide less environmental impact. This technology investment expands upon Attindas’ recent successful launches in North America and Spain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220112005197/en/

The new product design also improves user experience, providing a more comfortable, snug fit. By increasing elastic material from top to bottom throughout the product, it creates a protective underwear capable of fitting a wide range of body shapes and sizes.

“At Attindas we are driven to provide effective, affordable, and widely available solutions to help those with Adult Incontinence enjoy life with health, dignity, and comfort every day,” said Chad M. Lang, head of Global Marketing for Attindas. “This innovation in protective underwear delivers an experience that’s more like wearing traditional underwear for our consumers, while enhancing the sustainability profile of our product assortment. We’re excited for users of our protective underwear, and those retailer partner brands we support in Europe, to experience this new product, as we flow this innovation to them for their next purchase.”

Promotional video for Attends® Pull-On protective underwear:
https://youtu.be/Hqok7g5L1LY

About Attindas

Based in Raleigh, NC, USA, Attindas Hygiene Partners brings together a portfolio of companies including Attends Healthcare Products, Associated Hygienic Products, and HDIS in North America, and Laboratorios Indas and Attends Healthcare AB in Europe. Attindas designs, manufactures, and markets absorbent hygiene products for US, Canada, Europe and export markets worldwide. The company’s main business lines include adult incontinence and infant diapers, among other products, for the healthcare, retail, and direct-to-consumer channels under its well-known brands including Attends, Incopack, Indasec, Chelino, and Comfees. Attindas additionally supplies as a wide range of private label brands for retailers in North America and Europe. Learn more at www.attindas.com .

Attindas Hygiene Partners
8020 Arco Corporate Drive, Suite 200, Raleigh, NC 27617
919-237-4000
contact@attindas.com
www.attindas.com

Link:

ClickThru

Social Media:

https://www.facebook.com/attindas

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 202627.5.2026 23:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy demonstrated statistically significant overall survival benefit with an unprecedented seven-month improvement in first-line HER2+ GEAOral presentation at ASCO highlights benefit regardless of PD-L1 status, including in PD-L1 <1% BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be presented in an oral presentation (Rapid Oral Abstract: 4010) at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2026, in Chicago.The HERIZON-GEA-01 clinical trial evaluated ZIIHERA® (zanidatamab) plus chemotherapy, with and without TEVIMBRA® (tislelizumab), compared with the control arm of trastuzumab plus chemotherapy as first-line treatment for advanced/metastatic HER2+ gastroesophageal adenocarcinoma (GEA). Dr. Sun Young Rha, Professor of Medical Oncology at the Yonsei Cancer Center, Yonsei Univ

Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards27.5.2026 17:22:00 CEST | Press release

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental factors which impact allergies, is delighted to announce the recipients of the 2025 edition of its prestigious Science Awards for Allergy. Building on the success of the previous edition, this year’s awards recognise outstanding contributions to allergy research and patient engagement and allocate a total of €100,000 to support these initiatives. Four researchers have been selected by the Board as award recipients, each receiving €25,000 across two categories: Innovation In Treatment Awards Assoc. Professor Alexander Eggel, PhD, Department for Biomedical Research, University of Bern, and Department of Rheumatology and Immunology, University Hospital Bern, Switzerland, recognised for his research: “Improving diagnostic and therapeutic options for allergic patients”; Dr Janice A. Layhadi, PhD, Research Associate, National Heart and Lung Institute, Imperial College

Capchase Secures $200M+, as Demand for Vendor Financing in Enterprise Tech Deals Accelerates27.5.2026 16:00:00 CEST | Press release

As buyers face tighter budgets, Capchase helps technology companies close more deals faster with AI-enabled instant financing Capchase, the leading vendor financing platform for enterprise tech, today announced $200M+ in incremental funding to scale its embedded financing infrastructure globally and deploy more AI-enabled features. The funding, a mix of debt warehouse facilities and equity backed by institutional investors, reflects market validation that vendor financing has become essential infrastructure for enterprise technology companies to sell hardware and software products. As global B2B buyers face tighter budgets and greater scrutiny over large, up-front purchases, financing demand is growing. The Market Shift: Financing as a Growth Lever for B2B Tech Companies The $1.3 trillion vendor financing market has been traditionally dominated by banks and other lenders that utilize multi-thread email chains to manual doc review for underwriting. Capchase replaces those bottlenecks wi

ClickHouse Tops $250M ARR and 4,000 Customers, Launches Claude-Powered Agents at Open House 202627.5.2026 15:00:00 CEST | Press release

Annual run-rate revenue more than tripled year-over-year; new CostBench benchmark shows ClickHouse Cloud at 23x better cost-performance than the nearest cloud data warehouse ClickHouse today opened Open House 2026, its second annual user conference, with a set of announcements that mark one of the company's most active quarters since founding. ClickHouse’s serverless cloud offering has crossed over $250 million in annual run-rate revenue — more than triple a year ago — and added more than 1,000 net new customers since January, bringing its total to 4,000. To meet the demands of AI-era workloads, the company also launched ClickHouse Agents, a fully managed agentic analytics service powered by Anthropic's Claude; published CostBench, an open benchmark comparing the major cloud data warehouses on cost-performance; and introduced House Mates, its first formal partner program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527

Wasabi and Liverpool FC Renew Multi-year Partnership to Scale Global Fan Growth27.5.2026 15:00:00 CEST | Press release

Wasabi remains official cloud storage partner of Liverpool FC during its worldwide expansion, helping fuel the Club’s global digital content strategy Wasabi Technologies, the hot cloud storage company, today announced a multi-year extension of its partnership with Liverpool Football Club (LFC), deepening its role as the club’s Official Cloud Storage Partner. The renewed deal will see Wasabi help power the next phase of LFC’s global content strategy through Wasabi AiR, the intelligent media storage service, enabling the club to move faster, scale smarter, and deliver more personalised fan experiences that bring supporters across the world closer to the club. Together, the partnership empowers LFC to create, store, find, and publish content faster, helping to deliver rapid match and social output and serve its global fanbase with richer, more dynamic storytelling. Meanwhile, LFC serves as a strategic partner in Wasabi’s worldwide expansion, with brand visibility that grows Wasabi’s partn

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye